US FDA OKs Mitsubishi Tanabe’s Oral Edaravone for ALS

Mitsubishi Tanabe Pharma said on May 13 that the US FDA has approved an oral suspension version of its ALS therapy Radicava (edaravone). The drug has been only available in IV forms up to now, and the new version will...read more